Search
  • Philip Hockberger

Northwestern’s Chemistry of Life Processes Institute Hatches IPO of the Decade

January 28, 2020 - What happens when a highly interdisciplinary and integrated team of scientists, business leaders and students work together across fields of fundamental science, discovery, development, and finance? In the case of Monopar Therapeutics, a Chemistry of Life Processes Institute-affiliated spin-out, it leads to a record-breaking initial public offering.


Last month, Monopar (MNPR), a clinical stage biopharmaceutical company that develops proprietary therapeutics for cancer, experienced the “best first-day pop for an IPO since Baidu in 2005,” according to Nasdaq News. The company’s stock price rocketed 231 percent from its initial offering, reaching a market valuation of $289 million on its first day.


For more information, click here.

27 views0 comments

Recent Posts

See All

Mansueto, Polsky back Northwestern biotech spinout

by John Pletz, Carin's Chicago Business, May 6, 2021 A Northwestern University drug-development spinout has raised $4 million from investors including Morningstar founder Joe Mansueto. Grove Biopharma

CBIA and WIB partner on Work-Life Integration Survey

CBIA and Women In Bio (WIB) have published results of a survey that addresses the needs of professional women working in the life sciences. "The concept of work–life integration reflects a growing des